CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

CYP17 encodes cytochrome p450c17alpha, which mediates activities essential for the production of sex steroids. Common germ line variation in the CYP17 gene has been related to inconsistent results in breast and prostate cancer, with most studies focusing on the nonsynonymous single nucleotide polymo...

Full description

Bibliographic Details
Main Authors: Setiawan, V, Schumacher, F, Haiman, C, Stram, DO, Albanes, D, Altshuler, D, Berglund, G, Buring, J, Calle, E, Clavel-Chapelon, F, Cox, D, Gaziano, J, Hankinson, SE, Hayes, R, Henderson, B, Hirschhorn, J, Hoover, R, Hunter, D, Kaaks, R, Kolonel, L, Kraft, P, Ma, J, Le Marchand, L, Linseisen, J, Lund, E
Format: Journal article
Language:English
Published: 2007

Similar Items

Similar Items